Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 25 of LISATA THERAPEUTICS, INC.'s SEC filings and found 3 warrant series, 3 convertibles, 1 ATM program, 1 shelf registration and 2 completed offerings on file for LSTA. The latest dilution event on file is an offering on Sep 17, 2026. Analysis updated Oct 6, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
GUTSFractyl Health, Inc.
LPCNLipocine Inc.
PBMPsyence Biomedical Ltd.
CLRBCellectar Biosciences, Inc.
SYBXSynlogic, Inc.
INTSIntensity Therapeutics, Inc.
TVRDTvardi Therapeutics, Inc.
PASGPassage Bio, Inc.
GDTCCytoMed Therapeutics Limited Ordinary Shares
ICUSeaStar Medical Holding Corporation
HINDVyome Holdings, Inc.
GTBPGT Biopharma, Inc.
TCRXTScan Therapeutics, Inc.
PHIOPhio Pharmaceuticals Corp.
DAREDare Bioscience, Inc.